88 related articles for article (PubMed ID: 16749367)
1. Total ovulating period: any contribution to ovarian carcinogenesis?
Odukogbe AA; Adebamowo CA; Adeniji AO; Omigbodun AO; Olayemi O; Oladokun A; Owolabi MS; Aimakhu C; Adewole IF; Owoaje E
Afr J Med Med Sci; 2005 Sep; 34(3):307-9. PubMed ID: 16749367
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer in Ibadan: characteristics and management.
Odukogbe AA; Adebamowo CA; Ola B; Olayemi O; Oladokun A; Adewole IF; Omigbodun OA; Aimakhu CO; Okunlola MA; Fakulujo O; Oluyemi FA
J Obstet Gynaecol; 2004 Apr; 24(3):294-7. PubMed ID: 15203632
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of the transient decrease in ovarian cancer risk following childbirth.
Liu Q; Lambe M; Baik I; Cnattingius S; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2508-13. PubMed ID: 17164377
[TBL] [Abstract][Full Text] [Related]
4. The association of parity and marital status with the development of ovarian carcinoma: clinical implications.
Demopoulos RI; Seltzer V; Dubin N; Gutman E
Obstet Gynecol; 1979 Aug; 54(2):150-5. PubMed ID: 460747
[TBL] [Abstract][Full Text] [Related]
5. [Reproductive activities as risk factors of epithelial ovarian cancer: a case-control epidemiologic study].
Chen Y
Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):158-61, 188. PubMed ID: 1874060
[TBL] [Abstract][Full Text] [Related]
6. [Significance of ovulatory age in the pathogenesis of ovarian cancer].
Langer M; Gitsch E; Salzer H
Geburtshilfe Frauenheilkd; 1984 Jun; 44(6):366-7. PubMed ID: 6564976
[TBL] [Abstract][Full Text] [Related]
7. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer.
Terry KL; Titus-Ernstoff L; McKolanis JR; Welch WR; Finn OJ; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):30-5. PubMed ID: 17220329
[TBL] [Abstract][Full Text] [Related]
8. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
9. Reproductive factors in relation to ovarian cancer: a case-control study in Northern Vietnam.
Le DC; Kubo T; Fujino Y; Sokal DC; Vach TH; Pham TM; Matsuda S
Contraception; 2012 Nov; 86(5):494-9. PubMed ID: 22579106
[TBL] [Abstract][Full Text] [Related]
10. [Ovulation induction therapy and malignant ovarian cancer].
Göcze P; Krommer K; Csermely T; Cziráky K; Garamvölgyi Z; Kovács K; Szabó I
Orv Hetil; 2000 Jan; 141(2):71-5. PubMed ID: 10686780
[TBL] [Abstract][Full Text] [Related]
11. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.
Soegaard M; Jensen A; Høgdall E; Christensen L; Høgdall C; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1160-6. PubMed ID: 17548679
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of ovarian granulosa cell tumors: a case-control study.
Boyce EA; Costaggini I; Vitonis A; Feltmate C; Muto M; Berkowitz R; Cramer D; Horowitz NS
Gynecol Oncol; 2009 Nov; 115(2):221-5. PubMed ID: 19664811
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein concentrations and subsequent ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
[TBL] [Abstract][Full Text] [Related]
15. [Ovulation induction and the risk of ovarian tumors].
Franco C; Coppola S; Prosperi Porta R; Patella A
Minerva Ginecol; 2000 Apr; 52(4):103-9. PubMed ID: 10900940
[TBL] [Abstract][Full Text] [Related]
16. Beyond parity: association of ovarian cancer with length of gestation and offspring characteristics.
Jordan SJ; Green AC; Nagle CM; Olsen CM; Whiteman DC; Webb PM; ;
Am J Epidemiol; 2009 Sep; 170(5):607-14. PubMed ID: 19638480
[TBL] [Abstract][Full Text] [Related]
17. Intake of specific carotenoids and the risk of epithelial ovarian cancer.
Zhang M; Holman CD; Binns CW
Br J Nutr; 2007 Jul; 98(1):187-93. PubMed ID: 17367574
[TBL] [Abstract][Full Text] [Related]
18. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
Michelsen TM; Dørum A; Dahl AA
Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
